Ondansetron Tablet, Orally Disintegrating
Product Images NDC 55154-8339

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-8339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8mg Bag Label (B50c1767 8a50 49ab Be31 6533021ae7c4 00)

Ondansetron orally disintegrating tablets USP 8 mg, in a package of 10 tablets. The label includes dosage form as orally disintegrating tablets and notes storage conditions, usage instructions, and warnings. Manufactured by Aurobindo Pharma USA and distributed by Cardinal Health 107, LLC. NDC 55154-8339-0 is displayed.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron showing its molecular framework with ring systems and functional groups. The diagram depicts atoms and bonds characteristic of this antiemetic active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.